Trending
Everest Group Life Sciences Digital Services Specialists PEAK Matrix® Assessment 2024
We’re proud to have been named a Leader in the Everest Group Life Sciences Digital Services Specialists PEAK Matrix® Report. Everest Group classified ...
The Pricing Challenge Of Pharma's Shift To Specialty Medicines
The shift to specialty medicines has opened up for pharma companies a wealth of opportunities in addressing unmet medical needs of patients and improve the cost of care. This shift has also brought significant challenges, especially in the form of pricing and market access in an environment that is becoming increasingly resistant to higher cost drugs. This paper looks at the keys to success on ...
Challenges To Traditional Pharma Incentive Plan Design For Today’s Rapidly Changing Pharmaceutical Environment
Changes in emerging environmental trends facing the pharma industry are requiring companies to rethink different strategic and operational sales force plans that ultimately drive new outcome measures. Among these sales force changes are considerations to implement incentive compensation designs that move away from traditional Rx-volume measurement. Despite noted challenges, this paper explores ...
Table Size Optimization For Small Datasets In Amazon Redshift
Amazon Redshift is a fast, fully managed, petabyte-scale data warehouse, but to make it cost-efficient, one needs to be aware of some key factors that affect the table sizing and eventually performance. This paper highlights those nuances and also explains how to deal with the smaller datasets in the mix of massive datasets. The factors that affect the performance and sizing of the Redshift ...
Deploying K Nearest Neighbor Modeling Methodologies For Real World Problems
There has been an immense improvement of theory and algorithms in recent times leading to enhancement in computation power. Also, online data availability was never easier than now. As a result, machine learning techniques have become more popular in solving real world problems. There are a number of machine learning techniques available now for continuous as well as categorical target events. K ...
The Recent Woes Of Non-Bank Mortgage Servicers
Non-bank mortgage servicers have grown by leaps and bounds since the crisis. As they have become an integral part of the American dream of home ownership, they have also attracted increased scrutiny from the government. In order to sustain their recent growth, non-bank servicers should invest in improving operational effectiveness, build in tighter controls, and align their organizational goals ...
Telematics - Watching Your Every Move
With the US economic recovery, miles driven have also been showing a positive trend lately. What does all this mean? More cars, more miles, and more traffic on the road – all put together – it means more crashes! It’s no surprise that the total number of vehicle crashes has recently shown a halt in a declining trend of several years and is expected to begin to rise again. More crashes imply more ...
Risk Basel Methodology Implementation
Basel will have significant impact on the banking sector. One recent study1 estimated that as the Basel rules are written today; by 2019 the US banks will need about $870 billion of additional Tier 1 capital, $800 billion of short-term liquidity, and about $3.2 trillion of long-term funding, absent any mitigating actions. Closing these gaps will have a substantial impact on profitability. Just ...
Account Based Models In An Institutional Setting
The stakeholders and factors that drive the ultimate prescribing of a medication have shifted considerably since the turn of the century. Technological advances (i.e., EMR), cost pressures, quality initiatives, government regulations, and other factors have contributed to the rise and expansion of Integrated Delivery Networks (IDNs). The independence that physicians once experienced in their own ...
Payer Influence On Product Performance In Pharmaceutical Industry
Payers vary in their ability to assert formulary compliance. We will explore how tools and analytics can enable a pharmaceutical manufacturer to assess factors impacting formulary control and incorporate those findings when evaluating contracting opportunities. We apply these approaches to understand the various levers payers use to control product utilization and measure the direct and indirect ...